| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005053-199206000-00001 |
| P698 | PubMed publication ID | 1350613 |
| P2093 | author name string | C. S. Grob | |
| G. L. Bravo | |||
| M. B. Liester | |||
| R. N. Walsh | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 345-52; discussion 353-4 | |
| P577 | publication date | 1992-06-01 | |
| P1433 | published in | Journal of Nervous and Mental Disease | Q598644 |
| P1476 | title | Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use | |
| P478 | volume | 180 |
| Q51073688 | (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. |
| Q47777762 | (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA. |
| Q34437998 | 3,4-methylenedioxymethamphetamine (MDMA): a review |
| Q43581726 | 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. |
| Q33907331 | Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans |
| Q41180408 | Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy'). |
| Q44449172 | Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function |
| Q35095703 | Altered states: the clinical effects of Ecstasy. |
| Q51381678 | Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. |
| Q37082483 | Ecstasy (MDMA) and oral health |
| Q54296991 | Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. |
| Q42761983 | Ecstasy and the dance of death |
| Q44418655 | Ecstasy: a review of scientific literature about MDMA |
| Q51932115 | Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence. |
| Q34820201 | Human Ecstasy use is associated with increased cortical excitability: an fMRI study. |
| Q33961393 | Mental disorders in ecstasy users: a prospective-longitudinal investigation |
| Q72670089 | Methylenedioxyamphetamine ('Ecstasy') associated keratopathy |
| Q73371204 | Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms |
| Q55043421 | Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation. |
| Q51002104 | Neurotoxicity and substance abuse: further fuel for regulatory dilemma. |
| Q44462580 | Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations |
| Q35105557 | Preventing Problems in Ecstasy Users: Reduce Use to Reduce Harm |
| Q48405043 | Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats |
| Q33677986 | The Health Effect of Psychostimulants: A Literature Review |
| Q48149811 | The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain |
| Q36734781 | The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review |
| Q33864810 | Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use. |
Search more.